Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Xenoantigen-dependent complement-mediated neutralization of LCMV glycoprotein pseudotyped VSV in human serum.

Pipperger L, Koske I, Wild N, Müllauer B, Krenn D, Stoiber H, Wollmann G, Kimpel J, von Laer D, Bánki Z.

J Virol. 2019 Jun 26. pii: JVI.00567-19. doi: 10.1128/JVI.00567-19. [Epub ahead of print]

2.

Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunity.

Dittmer U, Sutter K, Kassiotis G, Zelinskyy G, Bánki Z, Stoiber H, Santiago ML, Hasenkrug KJ.

FEMS Microbiol Rev. 2019 May 14. pii: fuz012. doi: 10.1093/femsre/fuz012. [Epub ahead of print]

PMID:
31087035
3.

Anal Ureaplasma spp. positivity among HIV positive men who have sex with men may be associated with high-risk-type HPV infections.

Borena W, Kruis S, Kitchen M, Taylor N, Gisinger M, Oberkofler H, Stoiber H, Zangerle R, von Laer D, Sarcletti M.

Int J Infect Dis. 2019 Jul;84:75-79. doi: 10.1016/j.ijid.2019.04.025. Epub 2019 May 2.

4.

Fcγ Receptor Type I (CD64)-Mediated Impairment of the Capacity of Dendritic Cells to Activate Specific CD8 T Cells by IgG-opsonized Friend Virus.

Bánki Z, Werner R, Riepler L, Rössler A, Müllauer B, Hegen V, Bayer W, Verbeek JS, Dittmer U, Stoiber H.

Viruses. 2019 Feb 8;11(2). pii: E145. doi: 10.3390/v11020145.

5.

Antibody opsonization enhances MAIT cell responsiveness to bacteria via a TNF-dependent mechanism.

Bánki Z, Krabbendam L, Klaver D, Leng T, Kruis S, Mehta H, Müllauer B, Orth-Höller D, Stoiber H, Willberg CB, Klenerman P.

Immunol Cell Biol. 2019 Jan 29. doi: 10.1111/imcb.12239. [Epub ahead of print]

PMID:
30695101
6.

Active Human Complement Reduces the Zika Virus Load via Formation of the Membrane-Attack Complex.

Schiela B, Bernklau S, Malekshahi Z, Deutschmann D, Koske I, Banki Z, Thielens NM, Würzner R, Speth C, Weiss G, Stiasny K, Steinmann E, Stoiber H.

Front Immunol. 2018 Oct 17;9:2177. doi: 10.3389/fimmu.2018.02177. eCollection 2018.

7.

Demographic and seasonal characteristics of respiratory pathogens in neonates and infants aged 0 to 12 months in the Central-East region of Tunisia.

Brini Khalifa I, Hannachi N, Guerrero A, Orth-Höller D, Bhiri S, Bougila J, Boughamoura L, Merchaoui SN, Sboui H, Mahdhaoui N, Schiela B, Laer DH, Boukadida J, Stoiber H.

J Med Virol. 2019 Apr;91(4):570-581. doi: 10.1002/jmv.25347. Epub 2018 Nov 21.

8.

Epidemiology and clinical profile of pathogens responsible for the hospitalization of children in Sousse area, Tunisia.

Brini I, Guerrero A, Hannachi N, Bouguila J, Orth-Höller D, Bouhlel A, Boughamoura L, Hetzer B, Borena W, Schiela B, Von Laer D, Boukadida J, Stoiber H.

PLoS One. 2017 Nov 17;12(11):e0188325. doi: 10.1371/journal.pone.0188325. eCollection 2017.

9.

Periodontal Ehlers-Danlos Syndrome Is Caused by Mutations in C1R and C1S, which Encode Subcomponents C1r and C1s of Complement.

Kapferer-Seebacher I, Pepin M, Werner R, Aitman TJ, Nordgren A, Stoiber H, Thielens N, Gaboriaud C, Amberger A, Schossig A, Gruber R, Giunta C, Bamshad M, Björck E, Chen C, Chitayat D, Dorschner M, Schmitt-Egenolf M, Hale CJ, Hanna D, Hennies HC, Heiss-Kisielewsky I, Lindstrand A, Lundberg P, Mitchell AL, Nickerson DA, Reinstein E, Rohrbach M, Romani N, Schmuth M, Silver R, Taylan F, Vandersteen A, Vandrovcova J, Weerakkody R, Yang M, Pope FM; Molecular Basis of Periodontal EDS Consortium, Byers PH, Zschocke J.

Am J Hum Genet. 2016 Nov 3;99(5):1005-1014. doi: 10.1016/j.ajhg.2016.08.019. Epub 2016 Oct 13.

10.

Complement component C5 recruits neutrophils in the absence of C3 during respiratory infection with modified vaccinia virus Ankara.

Price PJ, Bánki Z, Scheideler A, Stoiber H, Verschoor A, Sutter G, Lehmann MH.

J Immunol. 2015 Feb 1;194(3):1164-8. doi: 10.4049/jimmunol.1301410. Epub 2014 Dec 29.

11.

MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro.

Reynoso R, Laufer N, Hackl M, Skalicky S, Monteforte R, Turk G, Carobene M, Quarleri J, Cahn P, Werner R, Stoiber H, Grillari-Voglauer R, Grillari J.

Sci Rep. 2014 Aug 1;4:5915. doi: 10.1038/srep05915.

12.

Novel bifunctional single-chain variable antibody fragments to enhance virolysis by complement: generation and proof-of-concept.

Huber G, Bánki Z, Kunert R, Stoiber H.

Biomed Res Int. 2014;2014:971345. doi: 10.1155/2014/971345. Epub 2014 Jan 12.

13.

Issues on results of the external quality assessment for proviral DNA testing of HIV-1 tropism in the Maraviroc Switch collaborative study.

Berg J, Paar C, Stoiber H, Klimkait T.

J Clin Microbiol. 2013 Dec;51(12):4285-6. doi: 10.1128/JCM.02124-13. No abstract available.

14.

Inactivation of hepatitis C virus infectivity by human breast milk.

Pfaender S, Heyden J, Friesland M, Ciesek S, Ejaz A, Steinmann J, Steinmann J, Malarski A, Stoiber H, Tsiavaliaris G, Bader W, Jahreis G, Pietschmann T, Steinmann E.

J Infect Dis. 2013 Dec 15;208(12):1943-52. doi: 10.1093/infdis/jit519. Epub 2013 Sep 24.

PMID:
24068703
15.

The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting.

Atanackovic D, Reinhard H, Meyer S, Spöck S, Grob T, Luetkens T, Yousef S, Cao Y, Hildebrandt Y, Templin J, Bartels K, Lajmi N, Stoiber H, Kröger N, Atz J, Seimetz D, Izbicki JR, Bokemeyer C.

Hum Vaccin Immunother. 2013 Dec;9(12):2533-42. doi: 10.4161/hv.26065. Epub 2013 Aug 16.

16.

Complement factor H-derived short consensus repeat 18-20 enhanced complement-dependent cytotoxicity of ofatumumab on chronic lymphocytic leukemia cells.

Hörl S, Banki Z, Huber G, Ejaz A, Müllauer B, Willenbacher E, Steurer M, Stoiber H.

Haematologica. 2013 Dec;98(12):1939-47. doi: 10.3324/haematol.2013.089615. Epub 2013 Jul 12.

17.

Reduction of complement factor H binding to CLL cells improves the induction of rituximab-mediated complement-dependent cytotoxicity.

Hörl S, Bánki Z, Huber G, Ejaz A, Windisch D, Muellauer B, Willenbacher E, Steurer M, Stoiber H.

Leukemia. 2013 Nov;27(11):2200-8. doi: 10.1038/leu.2013.169. Epub 2013 Jun 13. Erratum in: Leukemia. 2013 Nov;27(11):2268.

18.

Specific acquisition of functional CD59 but not CD46 or CD55 by hepatitis C virus.

Ejaz A, Steinmann E, Bánki Z, Anggakusuma, Khalid S, Lengauer S, Wilhelm C, Zoller H, Schloegl A, Steinmann J, Grabski E, Kleines M, Pietschmann T, Stoiber H.

PLoS One. 2012;7(9):e45770. doi: 10.1371/journal.pone.0045770. Epub 2012 Sep 25.

19.

Targeting viral antigens to CD11c on dendritic cells induces retrovirus-specific T cell responses.

Ejaz A, Ammann CG, Werner R, Huber G, Oberhauser V, Hörl S, Schimmer S, Dittmer U, von Laer D, Stoiber H, Bánki Z.

PLoS One. 2012;7(9):e45102. doi: 10.1371/journal.pone.0045102. Epub 2012 Sep 17.

20.

Inhibition of human immunodeficiency virus replication by cell membrane-crossing oligomers.

Posch W, Piper S, Lindhorst T, Werner B, Fletcher A, Bock H, Lass-Flörl C, Stoiber H, Wilflingseder D.

Mol Med. 2012 Feb 10;18:111-22. doi: 10.2119/molmed.2011.00128.

21.

Emerging role for complement in HIV infection.

Huber G, Bánki Z, Lengauer S, Stoiber H.

Curr Opin HIV AIDS. 2011 Sep;6(5):419-26. doi: 10.1097/COH.0b013e3283495a26. Review.

PMID:
21825871
22.

Complement opsonization enhances friend virus infection of B cells and thereby amplifies the virus-specific CD8+ T cell response.

Bila C, Oberhauser V, Ammann CG, Ejaz A, Huber G, Schimmer S, Messer R, Pekna M, von Laer D, Dittmer U, Hasenkrug KJ, Stoiber H, Bánki Z.

J Virol. 2011 Jan;85(2):1151-5. doi: 10.1128/JVI.01821-10. Epub 2010 Nov 3.

23.

Complement as an endogenous adjuvant for dendritic cell-mediated induction of retrovirus-specific CTLs.

Bánki Z, Posch W, Ejaz A, Oberhauser V, Willey S, Gassner C, Stoiber H, Dittmer U, Dierich MP, Hasenkrug KJ, Wilflingseder D.

PLoS Pathog. 2010 Apr 29;6(4):e1000891. doi: 10.1371/journal.ppat.1000891.

24.

Complement, Fc receptors and antibodies: a Trojan horse in HIV infection?

Stoiber H.

Curr Opin HIV AIDS. 2009 Sep;4(5):394-9. doi: 10.1097/COH.0b013e32832f0108. Review.

PMID:
20048703
25.

Analysis of humoral immune responses in rhesus macaques vaccinated with attenuated SIVmac239Deltanef and challenged with pathogenic SIVmac251.

Freissmuth D, Hiltgartner A, Stahl-Hennig C, Fuchs D, Tenner-Racz K, Racz P, Uberla K, Strasak A, Dierich MP, Stoiber H, Falkensammer B.

J Med Primatol. 2010 Apr;39(2):97-111. doi: 10.1111/j.1600-0684.2009.00398.x. Epub 2009 Dec 9.

PMID:
20015159
26.

Induction of complement-mediated lysis of HIV-1 by a combination of HIV-specific and HLA allotype-specific antibodies.

Hildgartner A, Wilflingseder D, Gassner C, Dierich MP, Stoiber H, Bánki Z.

Immunol Lett. 2009 Sep 22;126(1-2):85-90. doi: 10.1016/j.imlet.2009.08.005. Epub 2009 Aug 19.

PMID:
19698750
27.

Role of complement and antibodies in controlling infection with pathogenic simian immunodeficiency virus (SIV) in macaques vaccinated with replication-deficient viral vectors.

Falkensammer B, Rubner B, Hiltgartner A, Wilflingseder D, Stahl Hennig C, Kuate S, Uberla K, Norley S, Strasak A, Racz P, Stoiber H.

Retrovirology. 2009 Jun 21;6:60. doi: 10.1186/1742-4690-6-60.

28.

Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome.

Orth D, Khan AB, Naim A, Grif K, Brockmeyer J, Karch H, Joannidis M, Clark SJ, Day AJ, Fidanzi S, Stoiber H, Dierich MP, Zimmerhackl LB, Würzner R.

J Immunol. 2009 May 15;182(10):6394-400. doi: 10.4049/jimmunol.0900151.

29.

Complement and antibodies: a dangerous liaison in HIV infection?

Stoiber H, Soederholm A, Wilflingseder D, Gusenbauer S, Hildgartner A, Dierich MP.

Vaccine. 2008 Dec 30;26 Suppl 8:I79-85. Review.

PMID:
19388170
30.

Epstein-barr virus-induced expression of a novel human vault RNA.

Nandy C, Mrázek J, Stoiber H, Grässer FA, Hüttenhofer A, Polacek N.

J Mol Biol. 2009 May 15;388(4):776-84. doi: 10.1016/j.jmb.2009.03.031. Epub 2009 Mar 17.

PMID:
19298825
31.

Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase.

Suh YS, Park KS, Sauermann U, Kim KS, Ahn SS, Franz M, Schulte R, Wilfingseder D, Stoiber H, Uberla K, Hunsmann G, Stahl-Hennig C, Sung YC.

Vaccine. 2008 Dec 2;26(51):6690-8. doi: 10.1016/j.vaccine.2008.07.055.

PMID:
18694796
32.

Potent human immunodeficiency virus-neutralizing and complement lysis activities of antibodies are not obligatorily linked.

Huber M, von Wyl V, Ammann CG, Kuster H, Stiegler G, Katinger H, Weber R, Fischer M, Stoiber H, Günthard HF, Trkola A.

J Virol. 2008 Apr;82(8):3834-42. doi: 10.1128/JVI.02569-07. Epub 2008 Jan 30.

33.

Complement-HIV interactions during all steps of viral pathogenesis.

Stoiber H, Banki Z, Wilflingseder D, Dierich MP.

Vaccine. 2008 Jun 6;26(24):3046-54. doi: 10.1016/j.vaccine.2007.12.003. Epub 2007 Dec 26.

PMID:
18191309
34.

Mhc class I haplotypes associated with survival time in simian immunodeficiency virus (SIV)-infected rhesus macaques.

Sauermann U, Siddiqui R, Suh YS, Platzer M, Leuchte N, Meyer H, Mätz-Rensing K, Stoiber H, Nürnberg P, Hunsmann G, Stahl-Hennig C, Krawczak M.

Genes Immun. 2008 Jan;9(1):69-80. Epub 2007 Dec 20.

PMID:
18094710
35.

Atraumatic oral spray immunization with replication-deficient viral vector vaccines.

Stahl-Hennig C, Kuate S, Franz M, Suh YS, Stoiber H, Sauermann U, Tenner-Racz K, Norley S, Park KS, Sung YC, Steinman R, Racz P, Uberla K.

J Virol. 2007 Dec;81(23):13180-90. Epub 2007 Sep 26.

36.

Oncostatin M-induced effects on EMT in human proximal tubular cells: differential role of ERK signaling.

Pollack V, Sarközi R, Banki Z, Feifel E, Wehn S, Gstraunthaler G, Stoiber H, Mayer G, Montesano R, Strutz F, Schramek H.

Am J Physiol Renal Physiol. 2007 Nov;293(5):F1714-26. Epub 2007 Sep 19.

37.

HIV-1 induced generation of C5a attracts immature dendriticcells and promotes infection of autologous T cells.

Soederholm A, Bánki Z, Wilflingseder D, Gassner C, Zwirner J, López-Trascasa M, Falkensammer B, Dierich MP, Stoiber H.

Eur J Immunol. 2007 Aug;37(8):2156-63.

38.

The central nervous system in mucosal vaccination of rhesus macaques with simian immunodeficiency virus Deltanef.

Georgsson G, Stahl-Hennig C, Tenner-Racz K, Uberla K, Stoiber H, Uguccioni M, Dierich M, Ignatius R, Steinman RM, Racz P.

Neuropathol Appl Neurobiol. 2007 Dec;33(6):644-57. Epub 2007 Jun 15.

PMID:
17573813
39.

IgG opsonization of HIV impedes provirus formation in and infection of dendritic cells and subsequent long-term transfer to T cells.

Wilflingseder D, Banki Z, Garcia E, Pruenster M, Pfister G, Muellauer B, Nikolic DS, Gassner C, Ammann CG, Dierich MP, Piguet V, Stoiber H.

J Immunol. 2007 Jun 15;178(12):7840-8.

40.

Subtype and genotypic resistance analysis of HIV-1 infected patients in Austria.

Falkensammer B, Doerler M, Kessler HH, Puchhammer-Stoeckl E, Parson W, Duftner C, Dierich MP, Stoiber H.

Wien Klin Wochenschr. 2007;119(5-6):181-5.

PMID:
17427022
41.

Lack of microbial DNA in tissue specimens of patients with abdominal aortic aneurysms and positive Chlamydiales serology.

Falkensammer B, Duftner C, Seiler R, Pavlic M, Walder G, Wilflingseder D, Stoiber H, Klein-Weigel P, Dierich M, Fraedrich G, Würzner R, Schirmer M; Innsbruck Abdominal Aortic Aneurysm Trial-Group.

Eur J Clin Microbiol Infect Dis. 2007 Feb;26(2):141-5.

PMID:
17216421
42.

Targeting human immunodeficiency virus type 1 with antibodies derived from patients with connective tissue disease.

Scherl M, Posch U, Obermoser G, Ammann C, Sepp N, Ulmer H, Dierich MP, Stoiber H, Falkensammer B.

Lupus. 2006;15(12):865-72.

PMID:
17211992
43.

Changes in HIV-specific antibody responses and neutralization titers in patients under ART.

Falkensammer B, Freissmuth D, Hübner L, Speth C, Dierich MP, Stoiber H.

Front Biosci. 2007 Jan 1;12:2148-58.

PMID:
17127452
44.

Float on: lipid rafts in the lifecycle of HIV.

Wilflingseder D, Stoiber H.

Front Biosci. 2007 Jan 1;12:2124-35. Review.

PMID:
17127449
45.

A single vaccination with attenuated SIVmac 239 via the tonsillar route confers partial protection against challenge with SIVmac 251 at a distant mucosal site, the rectum.

Stahl-Hennig C, Eisenblatter M, Franz M, Stoiber H, Tenner-Racz K, Suh YS, Jasny E, Falkensammer B, Ugucchioni M, Georgsson G, Baroni C, Dierich MP, Lifson JD, Steinman RM, Uberla K, Racz P, Ignatius R.

Front Biosci. 2007 Jan 1;12:2107-23.

PMID:
17127448
46.

Tracing complement-retroviral interactions from mucosal surfaces to the lymphatic tissue.

Banki Z, Soederholm A, Mullauer B, Dierich MP, Stoiber H.

Front Biosci. 2007 Jan 1;12:2096-106. Review.

PMID:
17127447
47.

Factor I-mediated processing of complement fragments on HIV immune complexes targets HIV to CR2-expressing B cells and facilitates B cell-mediated transmission of opsonized HIV to T cells.

Bánki Z, Wilflingseder D, Ammann CG, Pruenster M, Müllauer B, Holländer K, Meyer M, Sprinzl GM, van Lunzen J, Stellbrink HJ, Dierich MP, Stoiber H.

J Immunol. 2006 Sep 1;177(5):3469-76.

48.

Minimal residual disease in ovarian cancer as a target for complement-mediated mAb immunotherapy.

Bjørge L, Stoiber H, Dierich MP, Meri S.

Scand J Immunol. 2006 May;63(5):355-64.

49.

Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus.

Kuate S, Stahl-Hennig C, Stoiber H, Nchinda G, Floto A, Franz M, Sauermann U, Bredl S, Deml L, Ignatius R, Norley S, Racz P, Tenner-Racz K, Steinman RM, Wagner R, Uberla K.

Virology. 2006 Jul 20;351(1):133-44. Epub 2006 Apr 17.

50.

Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.

Suh YS, Park KS, Sauermann U, Franz M, Norley S, Wilfingseder D, Stoiber H, Fagrouch Z, Heeney J, Hunsmann G, Stahl-Hennig C, Sung YC.

Vaccine. 2006 Mar 10;24(11):1811-20. Epub 2005 Oct 25.

PMID:
16274888

Supplemental Content

Loading ...
Support Center